Evidence for a tumour suppressive function of APRG1 in breast cancer
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast
The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters
Timely withdrawal of G-CSF reduces the occurrence of thrombocytopenia during dose-dense chemotherapy
A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients
The role of X-linked genes in breast cancer
Incidence of male breast cancer in California, 1988-2000: racial/ethnic variation in 1759 men
Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?
Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration
Innate anti-breast cancer immunity of apoptosis-resistant human γδ-T cells
Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival